<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01829607</url>
  </required_header>
  <id_info>
    <org_study_id>FES-HFPEF</org_study_id>
    <nct_id>NCT01829607</nct_id>
  </id_info>
  <brief_title>Functional Electrical Stimulation of Peripheral Muscles in Heart Failure With Preserved Left Ventricular Ejection Fraction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Attikon Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Attikon Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of functional electrical stimulation of
      peripheral muscles on clinical and emotional status, endothelial function and left
      ventricular diastolic function in heart failure with preserved left ventricular ejection
      fraction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise capacity</measure>
    <time_frame>Six weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Six weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional status</measure>
    <time_frame>Six weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular diastolic function</measure>
    <time_frame>Six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>Six weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Neurohormonal activation</measure>
    <time_frame>Six weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Heart Failure With Preserved Left Ventricular Ejection Fraction</condition>
  <arm_group>
    <arm_group_label>Functional electrical stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Functional electrical stimulation of lower limbs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional electrical stimulation of peripheral muscles</intervention_name>
    <arm_group_label>Functional electrical stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        (i) symptoms [New York Heart Association (NYHA) class II or III] and signs typical of heart
        failure

        (ii) left ventricular (LV) ejection fraction (LVEF) &gt;50% and LV end-diastolic volume index
        &lt;97 mL/m2

        (iii) findings of left atrial (LA) dilatation (LA volume index &gt;40mL/m2), LV hypertrophy
        and/or LV diastolic dysfunction [ie, mitral E/A ratio &lt;1 or &gt;2, mitral E/e' ratio &gt;15 or
        8-15, (A pulmonary - A mitral) duration difference &gt;30 ms etc)

        (iv) no alterations in medical therapy during the previous 4 weeks

        (v) no myocardial infarction within 3 months prior to enrollment

        Exclusion Criteria:

        recent (â‰¤4 weeks) heart failure decompensation

          -  acute coronary syndrome

          -  chronic inflammatory diseases and malignancies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Attikon University Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2013</study_first_submitted>
  <study_first_submitted_qc>April 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2013</study_first_posted>
  <last_update_submitted>April 10, 2013</last_update_submitted>
  <last_update_submitted_qc>April 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Attikon Hospital</investigator_affiliation>
    <investigator_full_name>John Parissis</investigator_full_name>
    <investigator_title>Assistant Professor of Cardiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

